I-ne CO (4933) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Oct, 2026Executive summary
H1 FY2025 net sales rose 9.9% YoY to ¥22,321 million; EBITDA increased 15.2% to ¥2,547 million.
Operating profit fell 17.0% to ¥1,688 million, mainly due to M&A-related amortization; profit attributable to owners of parent declined 25.6% to ¥923 million.
EBITDA reached 104% of plan and operating profit 110%, while revenue was 97% of plan.
Financial highlights
Gross profit increased to ¥12,869 million from ¥10,867 million YoY.
Ordinary profit declined to ¥1,587 million from ¥2,143 million; basic EPS fell to ¥52.81 from ¥70.16.
Cost of sales ratio improved to 42.2% from 46.2%; selling-fee ratio rose 1.6 points as online sales mix expanded.
Revenue was ¥22.32bn versus ¥20.31bn YoY; EBITDA was ¥2.54bn versus ¥2.21bn, and operating income was ¥1.68bn versus ¥2.03bn.
Outlook and guidance
FY2025 forecasts remain unchanged: net sales ¥52,000 million, EBITDA ¥6,760 million, operating profit ¥5,040 million and profit attributable to owners of parent ¥2,700 million.
FY2025 basic EPS is forecast at ¥154.42.
H2 launches are planned at 81 versus 48 in H1: 44 haircare, 11 beauty-device and 26 skincare-and-other products, including promotional products.
New skincare and adjacent categories are planned, including 3–5 brands outside skincare; a new beauty-device brand was planned for late August 2025.
FY2028–30 targets are ¥100bn revenue, ¥14bn EBITDA and ¥11bn operating income; 2028 revenue and EBITDA thresholds also underpin performance-linked options.
Latest events from I-ne CO
- 9M sales rose 24.6%, while profits fell and FY2026 sales guidance increased.4933
Q3 2026 - H1 sales rose 20.1%, lifting guidance despite cost pressures and a lower full-year profit outlook.4933
Q2 2026 - Q1 revenue rose 22.4%, with profit gains outpacing sales growth; FY guidance was unchanged.4933
Q1 2025 - Sales and EBITDA grew, but attributable profit fell amid uneven category performance.4933
Q3 2025 - Q1 sales rose 12.4%, while profit fell amid higher investment and one-time losses.4933
Q1 2026 - Skincare and online growth lifted sales as acquisition costs and FY2026 guidance weighed on profit.4933
Q4 2025